Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Veruska Lia Fook Alves"'
Autor:
Rodrigo Carlini Fernando, Veruska Lia Fook Alves, Edgar Gil Rizzatti, Hatylas Azevedo, Alex Freire Sandes, David Martins, Gisele W. B. Colleoni, Maria Aparecida Dalboni, Diego R. Mazzotti, Mariana Bleker de Oliveira, Fabricio de Carvalho, Angela Isabel Pereira Eugênio
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-16 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-16 (2019)
A growing body of evidence suggests a key role of tumor microenvironment, especially for bone marrow mesenchymal stem cells (MSC), in the maintenance and progression of multiple myeloma (MM), through direct and indirect interactions with tumor plasma
Autor:
Veruska Lia Fook Alves, Djordje Atanackovic, Bruna Raphaeli Silva, Gisele W. B. Colleoni, Walter Moises Tobias Braga, Adriana Bruscato Bortoluzo
Publikováno v:
Immunotherapy. 6:569-575
Aim: The present study aimed at correlating the expression of cancer/testis antigens (CTAs) with the expression of genes related to tumor‐infiltrating T cells. Materials & methods: MAGE‐C1/CT‐7, MAGEA3/6, NY‐ESO‐1, LAGE‐1 and GAGE express
Autor:
Mariana Bleker de Oliveira, Daniela B Zanatta, Gisele W. B. Colleoni, Bryan E. Strauss, Veruska Lia Fook Alves, Angela Isabel Pereira Eugênio, Mihoko Yamamoto
Publikováno v:
Blood. 128:5658-5658
Introduction: HSP70 has an integrative role in protein degradation due to the interaction with many pathways, such as ubiquitin proteasome (UPS), unfolded protein response (UPR) and autophagy. In multiple myeloma (MM) HSP70 is overexpressed and helps
Autor:
Daniela Teixeira, Rodrigo Carlini Fernando, Mihoko Yamamoto, Veruska Lia Fook Alves, Paola Marino Dantonio, Gisele W. B. Colleoni, Alexandre S. Basso, Mariana Bleker de Oliveira
Publikováno v:
Blood. 128:4434-4434
Background: Despite the increase in patients' survival over the last years, multiple myeloma (MM) remains incurable, being persistence of cancer stem cells (CSCs) a probable cause of drug resistance and disease relapse. It is possible to isolate thes
Autor:
Mihoko Yamamoto, Angela Isabel Pereira Eugênio, Rodrigo Carlini Fernando, Veruska Lia Fook Alves, Mariana Bleker de Oliveira, Gisele W. B. Colleoni
Publikováno v:
Blood. 128:5663-5663
Background: Despite the absence of JAK1 and JAK2 mutations in multiple myeloma (MM), high levels of IL-6 constitutively activate the JAK/STAT pathway promoting survival and proliferation of tumor cells. Therefore, pharmacological inhibition of JAK pr
Autor:
Gisele W. B. Colleoni, Walter Moises Tobias Braga, Celso Vieira Xavier, Veruska Lia Fook Alves, Fabricio de Carvalho
Publikováno v:
Cancer immunology, immunotherapy : CII. 62(1)
The exact function of MAGE-C1/CT7 and MAGE-C2/CT10 is not yet understood in multiple myeloma (MM). However, the homologs MAGE-C1/CT7 and MAGE-C2/CT10 genes encode highly immunogeneic cancer/testis antigens (CTAs) and can be potential targets for T ce
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Review on TRIAP1 (TP53 regulated inhibitor of apoptosis 1), with data on DNA, on the protein encoded, and where the gene is implicated.
Autor:
Veruska Lia Fook Alves, Daniela B Zanatta, Bryan E. Strauss, Gisele W. B. Colleoni, Rodrigo Carlini Fernando, Angela Isabel Pereira Eugênio, Mariana Bleker de Oliveira
Publikováno v:
Cancer Research. 75:1017-1017
Introduction: Some evidences suggest that heat shock protein 70 (HSP70) is overexpressed in many types of cancer, providing a selective advantage for tumor cell survival, due in part, to its ability to inhibit cell death via APAF1 (apoptosis protease
Publikováno v:
Blood. 124:5175-5175
Introduction: Some evidences suggest that heat shock protein 70 (HSP70) is overexpressed in many types of cancer, and that high expression of this chaperone is linked with increasing tumor grade and/or poor prognosis. The overexpression of HSP70 may
Autor:
Veruska Lia Fook Alves, Gisele W. B. Colleoni, Walter Moises Tobias Braga, Fabricio de Carvalho, Bryan E. Strauss, Maria de Lourdes Lopes Ferrari Chauffaille, Daniela Bertolli Zanatta
Publikováno v:
Blood. 122:3771-3771
Introduction Some evidences show that HSP70 is overexpressed in many cancers, and that high expression of this chaperone correlates with increased tumor grade and/or poor prognosis. Overexpression of HSP70 can provide a selective survival advantage t